Trade Mark Journal No.2026/040 2 October 2026

WO0000001937977 (5)

Office of origin: United States of America

Date of International Registration:13 August 2026
Date of designation in the UK: 13 August 2026
Image for mark 1937977 KYEMPLI

International priority date claimed: 30 July 2026 (United States of America) (50023689)
Class 5
Pharmaceutical preparations for the treatment and prevention of neurodegenerative diseases, lysosomal storage diseases, and genetic diseases.

Denali Therapeutics Inc.

Representative: Chelseaa Larsen Sheppard Mullin Richter & Hampton, LLP, 1540 El Camino Real,, Suite 120, Menlo Park CA 94025, UNITED STATES OF AMERICA